Background: Primary screening for VRE with PCR directed against vanA allowed identification of vanA! samples from which VRE could not be isolated when selective culture methods were used. From such a sample a vancomycin-susceptible, vanA! Enterococcus faecium, Efm-V1511, was isolated, when vancomycin selection was not used during culture. Similar isolates with variable susceptibility to vancomycin were obtained in the following months.
Introduction
The majority of VRE isolates in Denmark are Enterococcus faecium containing the vanA gene that confers high-level resistance to vancomycin. 1 The vanA gene cluster is usually located on plasmids within Tn1546-derived gene structures. The vanA gene itself encodes D-Ala-D-Lac-ligase, which synthesizes precursors for peptidoglycan transpeptidation containing a terminal D-lactate inappropriate for vancomycin binding. However, the activities of VanH, a pyruvate dehydrogenase, and VanX, a D-Ala-D-Ala-dipeptidase, which counteracts the action of cellular D-Ala-D-Ala-ligase (Ddl), are both also required for vancomycin resistance. 2, 3 The expression of vanHAX is regulated by a two-component system, vanRS, also present within the Tn1546 structure. 4 In our department, VRE screening was changed from primary culture to a laboratory-developed PCR to detect the presence of vanA and vanB. This screening methodology identified occasional samples that tested vanA! by PCR, but from which VRE could not be recovered using selective culture. From some of these samples vanA!, vancomycin-susceptible E. faecium was isolated, if unselective agar was used for culture. Here, we describe the emergence of such vancomycin-variable E. faecium; we characterize the plasmid carrying the variant vanA gene cluster and the isolates' capability of developing vancomycin resistance.
Methods

VRE screening
VRE screening samples were obtained as faecal swabs (Copan) and inoculated into selective brain heart infusion broth containing 4 mg/L vancomycin and 60 mg/L aztreonam. After overnight incubation, the broth cultures were assayed for the presence of vanA and vanB by a laboratorydeveloped TaqMan assay. Ten microlitres of enrichment broth from samples testing positive for vanA was inoculated onto CHROMID VRE plates V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
(bioMérieux) containing 8 mg/L vancomycin and incubated for up to 48 h. vanA! samples that did not yield growth of VRE on selective plates were then inoculated (100 lL) onto unselective blood agar plates (DBA, SSI Diagnostika) and enterococcal isolates were tested again by PCR.
Sequencing of isolates and plasmids
WGS of bacterial isolates was done as previously described. 5 All reads were deposited at NCBI (accession number PRJEB25215).
The sequences of pHVH-V1511 (accession number LT986680) and pHVH-V1877.2 (accession number LT986681) were obtained by scaffolding contigs from the WGS assembly of Efm-V1511 to Ef_DMG1500501 plasmid 4 (accession number LT603681) and to reads obtained by Oxford Nanopore MinION sequencing, respectively. The derived structures were verified by PCR and Sanger sequencing (Table S1 , available as Supplementary data at JAC Online).
Results
Efm-V1511 was isolated from a rectal swab surveillance sample that only yielded growth when unselective plates were used for culture. The isolate was vanA! using PCR and the MIC of vancomycin was 4 mg/L ( Figure S1 ). Sequencing showed the isolate belonged to ST1421.
The sequence of the vanA-carrying plasmid of Efm-V1511, pHVH-V1511, was compared with a 50 640 bp plasmid from Australia (accession number LT603681) and a 58 211 bp plasmid from Korea (accession number CP01995) ( Figure 1 ). Both pHVH-V1511 and LT603681 contained an 11 bp deletion of vanY caused by the insertion of an IS1216E element in the 3 0 end of vanY. pHVH-V1511 contained an additional 373 bp deletion comprising 252 bp of the 3 0 end of vanX and the following 121 bp upstream of the IS1216E element ( Figure 1 ). The resulting 125 aa VanX protein encoded by pHVH-V1511 likely explained the vancomycin susceptibility of Efm-V1511 as VanX dipeptidase activity is necessary for resistance. As the function of VanX is to counteract the activity of Ddl, we searched for changes in ddl and vanRS. VanR is a transcriptional activator of vanHAX. 4 In the absence of induction, nonphosphorylated VanS negatively regulates VanR function and loss of VanS function results in constitutive expression of vanHAX. 6 Three isolates (V1873, V1874 and V1906) contained a P180S mutation in ddl, previously shown to impair the function of Ddl, 7 accompanied by a deletion of nt 17 in the vanS gene. One isolate (V1880) had a single nt insertion in ddl accompanied by an ISfae4 element insertion in vanS. Two isolates (V1485 and V1555) contained frameshift indels and a single isolate (V1402) contained an insertion of an IS1062-like element within the ddl gene unaccompanied by changes in vanRS. All isolates except V1402 exhibited vancomycin resistance. Finally, isolate V1886 had a vancomycin MIC of 4 mg/L and a G99E mutation of unknown significance in ddl without accompanying changes in vanRS. None of the isolates was dependent on vancomycin for growth.
The copy number of plasmid pHVH-V1511 was estimated by the ratio between average sequence coverage of pHVH-V1511 (excluding ISs) and six housekeeping genes, and varied between isolates from 2.5 to 32.7. Isolates in which loss of both ddl and vanS function explained vancomycin resistance (V1873, V1874, V1880 and V1906) had a low copy number of pHVH-V1511, between 2.5 and 3.8. In contrast, isolates with loss of only ddl function (V1402, V1485 and V1555) all showed high copy numbers, between 15.8 and 27.7, suggesting that increased pHVH-V1511 copy number may compensate for loss of Ddl activity. vanX-truncated vancomycin-variable enterococci JAC Figure 2 . Phylogeny of ST1421 E. faecium. The phylogenetic reconstruction shows Australian and Korean isolates to be closely related to the Copenhagen cluster of ST1421 isolates indicating a recent common ancestor. In the vanX and ddl columns the green boxes indicate presence and the empty red boxes indicate insertion/deletion or missense mutation within the respective gene. For the column marked pHVH-V1877.2, a green box indicates the presence of the plasmid. The column marked pHVH-V1511 shows the copy number of the pHVH-V1511 plasmid in the Danish and Australian samples in the form of a heatmap. The plasmid copy number was calculated as the ratio of the mean read depth of the pHVH-V1511 sequence without IS elements and the mean read depth of six housekeeping genes (ddl, atpA, gdh, purK, gyd and adk) using Bowtie2. 20 The column marked MIC (vancomycin) shows the vancomycin MICs (determined by Etest) for the Danish isolates in the form of a heatmap. Explanatory keys for the two heatmaps are included in the figure.
Three isolates (V1851, V1877 and V1897) had vancomycin MICs 256 mg/L. Sequence analysis indicated the presence of an additional vanA-containing plasmid homologous to pHVH-V24 (accession number KX574671) coexisting with pHVH-V1511. The pHVH-V24 plasmid is a frequent vanA-carrying plasmid in VRE in Copenhagen. 8 The additional plasmid of V1877, pHVH-V1877.2, was sequenced and compared with pHVH-V24 and the ISMMS_VRE_1 plasmid ISMMS_VRE_p2 (CP012431) ( Figure S2 ). 9 pHVH-V1877.2 contained an intact vanX.
The relationship between vancomycin susceptibility and pHVH-V1511 copy number was further investigated by regression analyses of log 2 -transformed vancomycin MIC and plasmid copy number in 37 isolates with WT ddl genes and without vanA-carrying plasmids other than pHVH-V1511. We observed a significant positive correlation (Pearson correlation coefficient r " 0.653) between plasmid copy number and vancomycin MIC indicating that resistance to vancomycin was associated with increased pHVH-V1511 copy number ( Figure S3 ).
To investigate whether vancomycin resistance could be selected for in vitro, Efm-V1511 and Efm-V1487 were passaged in the presence of vancomycin. For Efm-V1511, a vancomycindependent resistant variant with inactivated Ddl caused by insertion of an ISfae4 element within ddl was obtained ( Figure S4 ). From this, a vancomycin-independent resistant variant could be generated with an increased copy number of pHVH-V1511 (copy number 26.8 compared with 5.1 in the parental isolate). From Efm-V1487, a resistant vancomycin-independent variant with a WT ddl gene was obtained with high copy number of pHVH-V1511 (copy number 23.8 compared with 4.9 in the parental isolate).
BLAST analysis of pHVH-V1511 identified related plasmids from Australia (LT603681) and Korea (CP019995). The Australian plasmid was part of a recently described sequencing project (BioProject PRJEB13012) comprising 66 E. faecium ST1421 isolates. 10 The Korean plasmid was part of BioProject PRJNA358851 comprising four E. faecium ST1421 isolates. The phylogeny of representatives of the 66 Australian isolates, the 4 Korean isolates and the 48 Danish isolates showed that although Danish, Australian and Korean isolates appeared closely related, the Danish isolates clustered separately ( Figure 2 ). All Australian and Korean isolates contained vanA plasmids containing an intact vanX gene.
To investigate whether isolates of Efm-ST1421 were associated with clinical disease, we tested all E. faecium blood culture isolates from 2016 and 2017 (n " 169) for the presence of vanA by PCR. This identified five ST1421 isolates testing positive for vanA with a vancomycin MIC 4 mg/L containing a truncated vanX gene.
Discussion
Vancomycin-variable enterococci have previously been reported. [11] [12] [13] [14] The cluster of vanA-carrying E. faecium strains described here shows variable resistance to vancomycin as all isolates harbour a deletion within vanX rendering the gene inactive; an identical truncation has previously been reported in a single isolate from Korea. 15 The vanD gene cluster contains a vanX D allele encoding a protein with low D-Ala-D-Ala-dipeptidase activity 16 and has been sporadically identified in the chromosome of enterococci. 7, 17, 18 Glycopeptide-resistant vanD-containing isolates all contain genetic changes within the chromosomal ddl gene, inactivating gene function, 7, 17 and either show vancomycin dependence or contain inactivating changes in vanS D conferring constitutive expression of vanD. Similar changes were observed in some isolates within the ST1421 cluster presented here. In contrast to vanD-type elements, the vanA operon in the strains described here was located on a plasmid and expression of resistance genes may depend on gene dosage effects. We found a significant correlation between plasmid copy number and vancomycin MIC. Furthermore, in strains with loss of ddl function upregulation of plasmid copy number was associated with growth independent of vancomycin.
The strains presented here are genetically related to strains previously obtained in Korea and in Australia that all contain an intact vanX gene and exhibit nosocomial transmission. 19 It remains elusive in which circumstances vanX deletions may confer selective advantages, but our experience shows that the clone is viable and spread nosocomially. Vancomycin-variable enterococci like the present cluster are likely to be underreported using standard culture methods. Consequently, we have implemented PCR screening for the presence of vanA and vanB of enterococci from all clinical samples.
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